MedTrace Logo

The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy

NCT02714998 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2016-03-22

No results posted yet for this study

Summary

The investigators aimed to investigate the effects of salpingectomy and Methotrexate administration on ovarian reserve in ectopic pregnancy.

Conditions

Interventions

DRUG

Methotrexate

single dose systemic methotrexate administration (50 mg/m2)

PROCEDURE

salpingectomy

Laparoscopic unilateral salpingectomy

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Ahmet M. Ergenoglu, Ass. Prof. · Ege University School of Medicine Department of Obstetrics and Gynecology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714998 on ClinicalTrials.gov